Search results for: 'mena vaccine market'

20 Dec 2022  |  Global  |  Technology Research

Advances and Growth Opportunities in RNA Vaccines

Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

Infographics

×

RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...

25 Aug 2021  |  Global  |  Technology Research

Emerging Materials Influence Global Vaccine Packaging: Technology Opportunity Analysis

Need for Better Primary Packaging Materials, Sustainable Options, and Customized Storage during Transport Drives New Product Development

Infographics

×

The materials used for pharmaceutical vaccine packaging vary, and many are well-established in the market for the transport and storage of vaccines. Despite the wide variety, some of the most used vaccine packaging materials remain challenged by glass delamination, instability, and pH alteration over time. The global COVID-19 pandemic has amplified...

Vaccine Delivery platforms: This section covers various nanoparticle-based vaccine delivery platforms such as nanoparticles of biological (self-assembling proteins) and non-biological origin ( inorganic and polymeric). The biological nanoparticles subsection overlaps with virus-like particles that has been separately addressed. Virus-Like Parti...

18 Apr 2022  |  North America  |  Market Research

Global Vaccine Growth Opportunities

Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally

Infographics

×

Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...

With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly, t...

17 Apr 2024  |  South Asia, Middle East & North Africa  |  Market Outlook

MENA Power and Energy Outlook and Growth Opportunities, 2024

Revenue from High Fossil Fuel Prices Drives Investment in Power Infrastructure

Infographics

×

This Frost & Sullivan study assesses the power and energy industry in the Middle East and North Africa (MENA). It broadly classifies MENA countries into 3 groups. The first group comprises most of the Gulf states, which have high levels of investment relative to their population size because the governments can fund power investment from oil and ga...

The Research Service provides analysis and assessment of the European Vaccines Market, maps the key trends and dynamics shaping the industry sector, provides valuable insights on pipeline analysis and competitive landscape and discusses the strategic recommendations for the success of the market participants. This study provides an in-depth analysi...

This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...